ALG-055009 in Non-cirrhotic Adults With MASH (HERALD)

A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

NCT06920043 ·Status: RECRUITING ·Phase: PHASE2

Study in Healthy Adults Evaluating PF-07202954

NCT04857437 ·Status: COMPLETED ·Phase: PHASE1

Study of NGM282 in Patients With Nonalcoholic Steatohepatitis (NASH)

NCT02443116 ·Status: COMPLETED ·Phase: PHASE2

Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial

NCT06138821 ·Status: RECRUITING ·Phase: NA

Phase 2a Study of HPG1860 in Subjects With NASH

NCT05338034 ·Status: UNKNOWN ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

NCT06419374 ·Status: RECRUITING ·Phase: PHASE3

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

NCT06318169 ·Status: RECRUITING ·Phase: PHASE3

A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis

NCT03486912 ·Status: COMPLETED ·Phase: PHASE2

A Study of ALN-HSD in Healthy Adult Subjects and Adult Patients With Nonalcoholic Steatohepatitis (NASH)

NCT04565717 ·Status: TERMINATED ·Phase: PHASE1

Different Doses of ZED1227 vs. Placebo in NAFLD

NCT05305599 ·Status: COMPLETED ·Phase: PHASE2

A Study Evaluating Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

NCT06161571 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Growth Hormone and Intrahepatic Lipid Content in Patients With Nonalcoholic Fatty Liver Disease

NCT02217345 ·Status: COMPLETED ·Phase: PHASE2

Phase 2 Study of MGL-3196 in Patients With Non-Alcoholic Steatohepatitis (NASH)

NCT02912260 ·Status: COMPLETED ·Phase: PHASE2

A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

NCT07221188 ·Status: RECRUITING ·Phase: PHASE3

Safety and Efficacy of Selonsertib in Adults With Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis

NCT03053050 ·Status: TERMINATED ·Phase: PHASE3

A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)

NCT07288138 ·Status: RECRUITING ·Phase: PHASE2

Saroglitazar Magnesium in the Treatment of Non-Alcoholic Steatohepatitis

NCT03863574 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate ALN-CIDEB in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease or With Metabolic Dysfunction-Associated Steatohepatitis (MASLD/MASH)

NCT06836609 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Phase 2a, Dose-ranging Study With PF-05221304 in Nonalcoholic Fatty Liver Disease (NAFLD)

NCT03248882 ·Status: COMPLETED ·Phase: PHASE2

Assessment of Non-Invasive Testing in Major Liver-Related Outcomes

NCT06986447 ·Status: ENROLLING_BY_INVITATION

A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis

NCT03486899 ·Status: COMPLETED ·Phase: PHASE2

A One-Year, Randomized, Double-Blind, Placebo-Controlled Trial of Rosiglitazone in Non-Alcoholic Steatohepatitis

NCT00492700 ·Status: COMPLETED ·Phase: PHASE2

A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES)

NCT05500222 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASH

NCT07335601 ·Status: RECRUITING ·Phase: PHASE2

A Study to Evaluate the Safety and Efficacy of Rencofilstat in Adult Subjects With NASH F3

NCT05461105 ·Status: COMPLETED ·Phase: PHASE2